Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Warren Buffett Buys More Shares of Phillips 66 (NYSE:PSX)

Page 1 of 2

Warren Buffett’s Berkshire Hathaway just bought more shares of Phillips 66 (NYSE:PSX). A Form 4 filed with the U.S. Securities and Exchange Commission disclosed Berkshire Hathaway’s acquisition of 3.51 million shares at an average price of $79.37 per share, lifting the holding company’s stake to nearly 61.49 million shares. The stake represents roughly 11.44% of Phillips 66’s outstanding common stock. Buffett’s firm revealed at the end of August that it had amassed a substantial position in the company.

Warren Buffet, is Warren Buffet success personified, Suzanne Woolley

Warren Buffett, known as the “Oracle of Omaha”, needs little to no introduction. He is an investment guru and one of the best and richest businessmen in the world. Buffett’s track record speaks for itself; he has managed to significantly outperform the broader market for a very long time. To be more specific, Buffett’s investment firm delivered an annual compound return of 22.3% between 1957 and 2014. Reportedly, Buffett’s most exceptional investment was buying the book “The Intelligent Investor” written by Benjamin Graham. In the meantime, Berkshire Hathaway oversees a public equity portfolio with a market value of $107.18 billion as of June 30. Buffett recently asserted that the low interest rate environment will likely have unforeseen consequences in the future.

Warren Buffett
Warren Buffett
Berkshire Hathaway

Hedge funds and other big money managers like Warren Buffett tend to have the largest amounts of their capital invested in large and mega-cap stocks like The Coca-Cola Company (NYSE:KO) because these companies allow for much greater capital allocation. That’s why if we take a look at the most popular stocks among funds, we won’t find any mid- or small-cap stocks there. However, our backtests of hedge funds’ equity portfolios between 1999 and 2012 revealed that the 50 most popular stocks among hedge funds underperformed the market by seven basis points per month, showing that their most popular picks and the ones that received the bulk of their capital were not actually their best picks. On the other hand, their top small-cap picks performed considerably better, outperforming the market by 95 basis points per month. This was confirmed through backtesting and in forward tests of our small-cap strategy since August 2012. The strategy, which involves imitating the 15 most popular small-cap picks among hedge funds has provided gains of 118%, beating the broader market by over 60 percentage points through the end of August (see the details).

Phillips 66 (NYSE:PSX) is a growing energy manufacturing and logistics company with high-performing midstream, chemicals, refining, and marketing and specialties businesses. Nevertheless, Warren Buffett and his team are “not buying it as a refiner” and “certainly not buying it as an integrated oil company”, per their own words; rather, they invest in it because they like the company and its management. The shares of Phillips 66 have gained nearly 13% since the beginning of the year, and have been greatly outperforming other energy companies this year. D.E. Shaw & Co., founded by David E. Shaw, and David Cohen and Harold Levy’s Iridian Asset Management are among the largest equity holders of Phillips 66 within our database, owning stakes of 11.58 million shares and 5.40 million shares, respectively.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!